We are live on ! Find out more
HARP

Harpoon Therapeutics, Inc. Common Stock
HARP

Delisted

HARP was delisted on the 8th of March, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Harpoon Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 41 → 0 (-41)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $175M → $0 (-$175M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 41

Holders
–
Holders Change
-41
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
41
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$22.6M
2
NLVP
New Leaf Venture Partners
New York
-$21.1M
3
CC
Commodore Capital
New York
-$17.1M
4
RCM
RA Capital Management
Massachusetts
-$17.1M
5
Franklin Resources
Franklin Resources
California
-$17M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
– -$22.6M -2,349,060 Closed
NLVP
2
New Leaf Venture Partners
New York
– -$21.1M -1,859,168 Closed
CC
3
Commodore Capital
New York
– -$17.1M -1,500,000 Closed
RCM
4
RA Capital Management
Massachusetts
– -$17.1M -1,500,000 Closed
Franklin Resources
5
Franklin Resources
California
– -$17M -1,492,368 Closed
AG
6
Artal Group
Luxembourg
– -$14.8M -1,304,127 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$10M -880,017 Closed
SCM
8
Soleus Capital Management
Connecticut
– -$9.33M -820,638 Closed
Blackstone Inc
9
Blackstone Inc
New York
– -$9.27M -815,000 Closed
Citadel Advisors
10
Citadel Advisors
Florida
– -$7.79M -685,000 Closed
ABG
11
Ally Bridge Group
New York
– -$4.87M -428,400 Closed
MB
12
MPM BioImpact
Massachusetts
– -$3.63M -319,670 Closed
MAM
13
MPM Asset Management
Massachusetts
– -$3.56M -313,136 Closed
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
– -$3.41M -300,000 Closed
SCM
15
Sio Capital Management
New York
– -$3.39M -297,936 Closed
BlackRock
16
BlackRock
New York
– -$2.84M -249,834 Closed
LPC
17
Lion Point Capital
New York
– -$2.6M -228,900 Closed
Geode Capital Management
18
Geode Capital Management
Massachusetts
– -$1.7M -149,262 Closed
KCM
19
Kennedy Capital Management
Missouri
– -$593K -52,160 Closed
Goldman Sachs
20
Goldman Sachs
New York
– -$557K -48,948 Closed
Citigroup
21
Citigroup
New York
– -$446K -39,222 Closed
Two Sigma Investments
22
Two Sigma Investments
New York
– -$307K -27,042 Closed
Aberdeen Group
23
Aberdeen Group
United Kingdom
– -$296K -25,991 Closed
Millennium Management
24
Millennium Management
New York
– -$290K -25,465 Closed
Northern Trust
25
Northern Trust
Illinois
– -$274K -24,080 Closed
1
2

HARP Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q1 2024, worth a combined $0 — down 100% from $175M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of HARP and 0 opened new positions — a net loss of 41 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $22.6M sold.

  • 0 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q1 2024, down from 41 in Q4 2023.
  • Funds reported $0 of Harpoon Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q1 2024 and 41 closed out, a net change of -41 holders.
  • The largest Harpoon Therapeutics, Inc. Common Stock seller in Q1 2024 was Cormorant Asset Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2024.